Rifabutin pharmacokinetics and safety among TB/HIV-coinfected children receiving lopinavir/ritonavir-containing second-line ART.
Rawizza HE, Oladokun R, Ejeliogu E, Oguche S, Ogunbosi BO, Agbaji O, Odaibo G, Imade G, Olaleye D, Wiesner L, Darin KM, Okonkwo P, Kanki PJ, Scarsi KK, McIlleron HM.
Rawizza HE, et al. Among authors: ejeliogu e.
J Antimicrob Chemother. 2021 Feb 11;76(3):710-717. doi: 10.1093/jac/dkaa512.
J Antimicrob Chemother. 2021.
PMID: 33294914
Free PMC article.